CSL Limited

$105.41
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$2.04 (-1.90%) Today
-$0.05 (-0.05%) As of 12:14 PM UTC after-hours

Why Robinhood?

You can buy or sell CSL Limited and other stocks, options, and ETFs commission-free!

About CSLLY

Csl Ltd SPONSORED ADR (Australia), also called CSL Limited, is a biopharmaceutical company, which engages in the manufacture, marketing, and distribution of biopharmaceutical and allied products. It operates through the CSL Behring and Seqirus segments. The CSL Behring segment provides plasma therapies and conducts early stage research on plasma and non plasma therapies. The Seqirus segment involves in the production of non-plasma biotherapeutic products and develops influenza related products. The company was founded on November 2, 1961 and is headquartered in Parkville, Australia. CSLLY is listed on the Pink Current market tier. OTC market data is provided by OTC Markets Group, Inc (otcmarkets.com). The listed name for CSLLY is Csl Ltd SPONSORED ADR (Australia).

CEO
Paul Roger Perreault
Employees
27,000
Headquarters
Parkville, Victoria (VIC)
Founded
1961
Market Cap
95.84B
Price-Earnings Ratio
35.94
Dividend Yield
0.85
Average Volume
67.66K
High Today
$108.28
Low Today
$105.46
Open Price
$107.43
Volume
50.61K
52 Week High
$117.98
52 Week Low
$75.19

CSLLY News

ReutersFeb 22

Australia shares slip on tech, healthcare losses

* Healthcare stocks fall as Aussie dollar firms * Miners benefit from soaring copper prices * Gold stocks up as bullion prices climb (Updates to close) Feb 2

You May Also Like

ERIC
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure